| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |